---
figid: PMC3502787__CHRP2012-817304.002
figlink: /pmc/articles/PMC3502787/figure/fig2/
number: F2
caption: Mechanisms by which HER3 contributes to resistance to EGFR-targeted therapy.
  (a) The oncogenic receptor tyrosine kinase MET could phosphorylate HER3, leading
  to activation of the PI3 K/Akt pathway independent of EGFR kinase activity []. (b)
  Lengthy exposure of cancer cells to TKIs can lead to Akt downregulation which consequently
  increases HER3 translocation from the cytoplasm to the membrane through a feedback
  regulation. The phosphorylation of HER3 recruits PI3 K and further activates the
  PI3 K/Akt pathway which plays an important role in resistance to EGFR-targeted therapy
  [].
pmcid: PMC3502787
papertitle: Advances in Targeting HER3 as an Anticancer Therapy.
reftext: Ning Jiang, et al. Chemother Res Pract. 2012;2012:817304.
pmc_ranked_result_index: '96287'
pathway_score: 0.9694747
filename: CHRP2012-817304.002.jpg
figtitle: Mechanisms by which HER3 contributes to resistance to EGFR-targeted therapy
year: '2012'
organisms: Homo sapiens
ndex: 16f40b8e-dec4-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3502787__CHRP2012-817304.002.html
  '@type': Dataset
  description: Mechanisms by which HER3 contributes to resistance to EGFR-targeted
    therapy. (a) The oncogenic receptor tyrosine kinase MET could phosphorylate HER3,
    leading to activation of the PI3 K/Akt pathway independent of EGFR kinase activity
    []. (b) Lengthy exposure of cancer cells to TKIs can lead to Akt downregulation
    which consequently increases HER3 translocation from the cytoplasm to the membrane
    through a feedback regulation. The phosphorylation of HER3 recruits PI3 K and
    further activates the PI3 K/Akt pathway which plays an important role in resistance
    to EGFR-targeted therapy [].
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3R6
  - PIK3R2
  - MET
  - AKT3
  - PIK3R4
  - AKT2
  - AKT1
  - PIK3R1
  - PIK3R3
  - PIK3R5
  - PIK3CA
  - PIK3CG
  - PIK3CD
  - PIK3CB
genes:
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3Kp85
  symbol: PI3K_p85
  source: bioentities_symbol
  hgnc_symbol: PIK3R2
  entrez: '5296'
- word: MET
  symbol: MET
  source: hgnc_symbol
  hgnc_symbol: MET
  entrez: '4233'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3Kp85
  symbol: PI3K_p85
  source: bioentities_symbol
  hgnc_symbol: PIK3R1
  entrez: '5295'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PKB
  symbol: PKB
  source: hgnc_alias_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
chemicals: []
diseases: []
figid_alias: PMC3502787__F2
redirect_from: /figures/PMC3502787__F2
figtype: Figure
---
